bioRxiv Science⌕ Search

Biology subjects

Licata, L.

Publications and source records attributed to Licata, L..

10 recordsLinked to original sources

Capturing domain-level detail of molecular interactions in the IMEx Consortium binding domain data set

The machinery of the cell depends on physical interactions, between proteins themselves, and between proteins and other biomolecules. The detailed characterisation of these interactions, including the identification of the precise sequence regions mediating binding events, is essential to understand both normal cell biology and disease mechanisms. Protein binding domains are specific regions of a protein sequence that mediate direct contact with a partner and represent a critical layer of functional annotation, bridging sequence, structure, and cellular function. Here we present the IMEx binding domain dataset, a large-scale, manually curated open-access set of molecular interactions assembled over more than two decades by the International Molecular Exchange (IMEx) Consortium. The dataset compiles experimentally derived binding region annotations from peer-reviewed literature, systematically linked to protein-protein interaction (PPI) records and mapped to standardised protein sequences in UniProtKB. We describe the curation model, data format, and content of the dataset, provide a descriptive and comparative analysis, and demonstrate the utility of the dataset as a gold standard for benchmarking interface prediction and variant effect annotation methods. Its integration with genomic variations further offers a route to elucidate the mechanistic basis of disease-associated mutations. The datasets are freely available through IntAct in the dedicated PSI-MI FeatureTAB format at https://ftp.ebi.ac.uk/pub/databases/intact/current/psimitab/features/ and are updated and enhanced with every release.

bioinformatics↗

BactMentha: a database of annotated bacteria-host protein interactions

Bacterial pathogens ensure their successful dissemination by employing specialized secretion systems to deliver a wide range of virulence proteins that interact with specific host proteins to modulate the response during infection. These interactions are often mediated by host-like elements, like short linear motifs, which can interfere with host interaction interfaces, enabling bacterial secreted proteins to compete and displace native partners of the targeted proteins. Several resources provide access to bacteria-host protein-protein interaction data. However, some are neither fully functional or up to date. Moreover, most of these databases lack virulence protein annotations, thus hampering hypothesis formulation based on protein interaction analyses. In this context, we have developed BactMentha, a unified resource that integrates bacterial-host protein-protein interactions for three organisms (human, mouse, and rat) with virulence protein annotations and bacterial strain clinical relevance information. BactMentha provides easy access to available experimentally identified binding regions of the interaction partners, complemented with putative interaction interfaces based on predicted structure complexes and on the detection of host-like elements on bacterial protein sequences interacting with human proteins. BactMentha currently contains 11 776 unique protein interactions between 2970 bacterial proteins, of which 684 have at least one virulence annotation, and 5088 host proteins. Experimentally identified binding regions are available for 532 bacteria-host interactions, most of which involve human proteins (440 interactions). Predicted interaction interfaces enabled a 3.7-fold increase in known and putative binding regions in the bacteria-human protein interaction data. By providing easy access to functionally annotated and clinically relevant protein interaction data, enriched with experimentally and predicted interaction interfaces, BactMentha can be instrumental in formulating novel hypotheses and speeding up wet lab research on the molecular mechanisms underlying pathogenic bacterial infections.

bioinformatics↗

Anonymized Somatic Tumor Twins (STTs) enable open genome data sharing and use in research and clinical oncology

The study of somatic variants from tumor genomes is fundamental to cancer research and clinical decision-making. However, existing data protection frameworks impose restrictions on the use and sharing of these variants in conjunction with sensitive germline information. To overcome these challenges, we developed GenomeAnonymizer, the first method to anonymize short-read DNA sequences from tumor-normal pairs. This generates Somatic Tumor Twins (STTs), an anonymized version of the original data that preserves the donors privacy while retaining somatic tumor information and sequencing noise. This method successfully removed all detectable germline variants from the 47 PCAWG-Pilot samples. We further demonstrate that Whole-Genome Sequencing (WGS) STTs preserve more than 98% of the original somatic variants, enabling reliable downstream analysis that replicates somatic-related findings from the original samples, including cancer driver genes, mutational signatures, and intratumor heterogeneity. Importantly, we also show that STTs can reproduce the identification of actionable genes and downstream clinical interpretations and decision-making. We generated a cancer cohort of STTs matched with synthetic clinical data that could be openly shared and used across projects and centers worldwide. This paradigm-shifting approach will accelerate discovery and clinical translation in oncology and enable the robust benchmarking of genome analysis and large-scale data infrastructures.

bioinformatics↗

An atlas of protein-protein associations of human tissues prioritizes candidate disease genes

Proteins that interact together participate in the same cellular process and influence the same organismal traits. Despite the progress in mapping protein-protein interactions we lack knowledge of how they differ between tissues. Due to coordinated (post)transcriptional control, protein complex members have highly correlated abundances that are predictive of functional association. Here, we have compiled 7873 proteomic samples measuring protein levels in 11 human tissues and use these to define an atlas with tissue-specific protein associations. This method recapitulates known protein complexes and the larger structural organization of the cell. Interactions of stable protein complexes are well preserved across tissues, while signaling and metabolic interactions show larger variation. Further, we find that less than 18% of differences between tissues are estimated to be due to differences in gene expression while cell-type specific cellular structures, such as synaptic components, represent a significant driver of differences between tissues. We further supported the brain protein association network through co-fractionation experiments in synaptosomes, curation of brain derived pull-down data and AlphaFold2 models. Together these results illustrate how this brain specific protein interaction network can functionally prioritize candidate genes within loci linked to brain disorders.

systems biology↗

The landscape of microRNA interactions annotation: analysis of three rare disorders as case study

In recent years, a huge amount of data on ncRNA interactions has been described in scientific papers and databases. Although considerable effort has been made to annotate the available knowledge in public repositories, there are still significant discrepancies in how different resources capture and interpret data on ncRNAs functional and physical associations. In the present paper, we have focused on microRNAs which regulate genes associated with rare diseases, as a case study to investigate data availability. The list of protein-coding genes with a known role in specific rare diseases was retrieved from the Genome England PanelApp, and associated microRNA-mRNA interactions were annotated in the IntAct database, and compared with other datasets. The annotation follows recognised standard criteria approved by the IMEX consortium. RNAcentral identifiers were used for unambiguous, stable identification of ncRNAs. The information about the interaction was enhanced by a detailed description of the cell types and experimental conditions, providing a computer-interpretable summary of the published data, integrated with the huge amount of protein interactions already gathered in the database. Furthermore, for each interaction, the binding sites of the microRNA are precisely mapped on a well-defined mRNA transcript of the target gene. This information is crucial to conceive and design optimal microRNA mimics or inhibitors, to interfere in vivo with a deregulated process. As these approaches become more feasible, high-quality, reliable networks of microRNA interactions are needed to help, for instance, in the selection of the best target to be inhibited and to predict potential secondary off-target effects.

bioinformatics↗

The landscape of cancer rewired GPCR signaling axes

We explored the dysregulation of GPCR ligand signaling systems in cancer transcriptomics datasets to uncover new therapeutics opportunities in oncology. We derived an interaction network of receptors with ligands and their biosynthetic enzymes, which revealed that multiple GPCRs are differentially regulated together with their upstream partners across cancer subtypes. We showed that biosynthetic pathway enrichment from enzyme expression recapitulated pathway activity signatures from metabolomics datasets, providing valuable surrogate information for GPCRs responding to organic ligands. We found that several GPCRs signaling components were significantly associated with patient survival in a cancer type-specific fashion. The expression of both receptor-ligand (or enzymes) partners improved patient stratification, suggesting a synergistic role for the activation of GPCR networks in modulating cancer phenotypes. Remarkably, we identified many such axes across several cancer molecular subtypes, including many pairs involving receptor- biosynthetic enzymes for neurotransmitters. We found that GPCRs from these actionable axes, including e.g., muscarinic, adenosine, 5-hydroxytryptamine and chemokine receptors, are the targets of multiple drugs displaying anti-growth effects in large-scale, cancer cell drug screens. We have made the results generated in this study freely available through a webapp (gpcrcanceraxes.bioinfolab.sns.it). SignificanceComprehensive analysis of GPCR extracellular network in cancer transcriptomics datasets reveals signaling axes associated to patient survival, whose targeting is associated with growth inhibition in cancer cell lines drug sensitivity assays.

bioinformatics↗

Curation of causal interactions mediated by genes associated to autism accelerates the understanding of gene-phenotype relationships underlying neurodevelopmental disorders

Autism spectrum disorder (ASD) comprises a large group of neurodevelopmental conditions featuring, over a wide range of severity and combinations, a core set of manifestations (restricted sociality, stereotyped behavior and language impairment) alongside various comorbidities. Common and rare variants in several hundreds of genes and regulatory regions have been implicated in the molecular pathogenesis of ASD along a range of causation evidence strength. Despite significant progress in elucidating the impact of few paradigmatic individual loci, such sheer complexity in the genetic architecture underlying ASD as a whole has hampered the identification of convergent actionable hubs hypothesized to relay between the vastness of risk alleles and the core phenotypes. In turn this has limited the development of strategies that can revert or ameliorate this condition, calling for a systems-level approach to probe the cross-talk of cooperating genes in terms of causal interaction networks in order to make convergences experimentally tractable and reveal their clinical actionability. As a first step in this direction, we have captured from the scientific literature information on the causal links between the genes whose variants have been associated with ASD and the whole human proteome. This information has been annotated in a computer readable format in the SIGNOR database and is made freely available in the resource website. To link this information to cell functions and phenotypes, we have developed graph algorithms that estimate the functional distance of any protein in the SIGNOR causal interactome to phenotypes and pathways. The main novelty of our approach resides in the possibility to explore the mechanistic links connecting the suggested gene-phenotype relations.

systems biology↗

The IMEx Coronavirus interactome: an evolving map of Coronaviridae-Host molecular interactions

The current Coronavirus Disease 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has spurred a wave of research of nearly unprecedented scale. Among the different strategies that are being used to understand the disease and develop effective treatments, the study of physical molecular interactions enables studying fine-grained resolution of the mechanisms behind the virus biology and the human organism response. Here we present a curated dataset of physical molecular interactions, manually extracted by IMEx Consortium curators focused on proteins from SARS-CoV-2, SARS-CoV-1 and other members of the Coronaviridae family. Currently, the dataset comprises over 2,200 binarized interactions extracted from 86 publications. The dataset can be accessed in the standard formats recommended by the Proteomics Standards Initiative (HUPO-PSI) at the IntAct database website (www.ebi.ac.uk/intact), and will be continuously updated as research on COVID-19 progresses.

bioinformatics↗

Myo-REG: a portal for signaling interactions in muscle regeneration

Muscle regeneration is a complex process governed by the interplay between several muscle resident mononuclear cell populations. Following acute or chronic damage these cell populations are activated, communicate via cell-cell interactions and/or paracrine signals, influencing fate decisions via the activation or repression of internal signaling cascades. These are highly dynamic processes, occurring with distinct temporal and spatial kinetics. The main challenge toward a system level description of the muscle regeneration process is the integration of this plethora of inter- and intra-cellular interactions.\n\nWe integrated the information on muscle regeneration in a web portal. The scientific content annotated in this portal is organized into two information layers representing relationships between different cell types and intracellular signaling-interactions, respectively. The annotation of the pathways governing the response of each cell type to a variety of stimuli/perturbations occurring during muscle regeneration takes advantage of the information stored in the SIGNOR database. Additional curation efforts have been carried out to increase the coverage of molecular interactions underlying muscle regeneration and to annotate cell-cell interactions.\n\nTo facilitate the access to information on cell and molecular interactions in the context of muscle regeneration, we have developed Myo-REG, a web portal that captures and integrates published information on skeletal muscle regeneration.\n\nThe muscle-centered resource we provide is one of a kind in the myology field. A friendly interface allows users to explore, approximately 100 cell interactions or to analyze intracellular pathways related to muscle regeneration. Finally, we discuss how data can be extracted from this portal to support in silico modeling experiments.

bioinformatics↗

CausalTab: PSI-MITAB 2.8 updated format for signaling data representation and dissemination

Combining multiple layers of information underlying biological complexity into a structured framework, and in particular deciphering the molecular mechanisms behind cellular phenotypes, represent two challenges in systems biology. A key task is the formalisation of such information in models describing how biological entities interact to mediate the response to external and internal signals. Several databases with signaling information, such as SIGNOR, SignaLink and IntAct, focus on capturing, organising and displaying signaling interactions by representing them as binary, causal relationships between biological entities. The curation efforts that build these individual databases demand a concerted effort to ensure interoperability among resources, through the development of a standardized exchange format, ontologies and controlled vocabularies supporting the domain of causal interactions. Aware of the enormous benefits of standardization efforts in the molecular interaction research field, representatives of the signalling network community agreed to extend the PSI-MI controlled vocabulary to include additional terms representing aspects of causal interactions. Here, we present a common standard for the representation and dissemination of signaling information: the PSI Causal Interaction tabular format (CausalTAB) which is an extension of the existing PSI-MI tab-delimited format, now designated MITAB2.8. We define the new term \"causal interaction\", and related child terms, which are children of the PSI-MI \"molecular interaction\" term. The new vocabulary terms in this extended PSI-MI format will enable systems biologists to model large-scale signaling networks more precisely and with higher coverage than before.

systems biology↗